Accuray Incorporated (NASDAQ: ARAY) announced data from a Phase 3 TomoBreast trial of TomoTherapy System (TT) versus conventional post-surgery radiotherapy (CR) for breast cancer designed to test the ...

SUNNYVALE, Calif., June 13, 2011 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that it has completed its previously announced acquisition of TomoTherapy Incorporated (Nasdaq: ...

SUNNYVALE, Calif., July 21, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today preliminary results from a prospective, phase II trial evaluating once-daily accelerated partial ...

Accuray Inc. ARAY recently announced the receipt of 510(k) clearance for its ClearRT Helical kVCT imaging for the Radixact treatment delivery system from the FDA. This latest development is expected ...

(Reuters) - Accuray Inc said it will acquire TomoTherapy Inc , a smaller rival in the radiation therapy system market, for about $277 million in a cash and stock deal. TomoTherapy shareholders will ...

A cancer diagnosis is hard enough; the challenges of treatment can be equally devastating. TomoTherapy, based in Madison Wisconsin, was founded with the goal of providing highly accurate radiation ...

With state-of-the-art equipment and some of the field’s top experts, UCLA Health has emerged as a leader in an approach to radiation therapy that can reduce toxicity and length of treatment while ...

Radixact X9 Tomotherapy launched at Max Institute of Cancer Care (MICC), Saket. For the first time in India, Radixact X9 Tomotherapy an advanced AI based cancer treatment technology - was launched at ...

Variation in gross tumor volume delineation using CT, MRI, and FDG-PET in planning radiotherapy of anal cancer. Background: Complete metastasectomy provides a real chance for long-term survival in ...

Chennai: In line with the mission to provide the most comprehensive and advanced cancer care in India, Apollo Proton Cancer Centre (APCC) has introduced the latest suite of cutting-edge ...